Cargando…

Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles–Adjuvanted Chlamydia Vaccine Elicits Elevated Protective Responses In The Lung

BACKGROUND: Chlamydia psittaci is a zoonotic bacteria closely associated with psittacosis/ornithosis. Vaccination has been recognized as the best way to inhibit the spread of C. psittaci due to the majority ignored of infections. The optimal Chlamydia vaccine was obstructed by the defect of single i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yumeng, Wang, Chuan, Sun, Zhenjie, Xiao, Jian, Yan, Xiaoliang, Chen, Yuqing, Yu, Jian, Wu, Yimou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790120/ https://www.ncbi.nlm.nih.gov/pubmed/31632026 http://dx.doi.org/10.2147/IJN.S218456

Ejemplares similares

Chlamydia psittaci Plasmid-Encoded CPSIT_P7 Elicits Inflammatory Response in Human Monocytes via TLR4/Mal/MyD88/NF-κB Signaling Pathway
por: Chen, Qian, et al.
Publicado: (2020)

Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract
por: Wern, Jeanette Erbo, et al.
Publicado: (2017)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics of intranasal and intramuscular administration of naloxone in working dogs administered fentanyl
por: Barr, Ciara A., et al.
Publicado: (2023)

Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis
por: Lorenzen, Emma, et al.
Publicado: (2015)

Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge
por: Zuo, Zonghui, et al.
Publicado: (2021)

Biodistribution and Adjuvant Effect of an Intranasal Vaccine Based on Chitosan Nanoparticles against Paracoccidioidomycosis
por: Santos Júnior, Samuel Rodrigues Dos, et al.
Publicado: (2023)

Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses
por: Si, Youhui, et al.
Publicado: (2018)

Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain
por: Liu, Shanshan, et al.
Publicado: (2018)

Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration
por: Zhao, Kai, et al.
Publicado: (2017)

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge
por: Mann, Alex J., et al.
Publicado: (2014)

Fusion-Expressed CTB Improves Both Systemic and Mucosal T-Cell Responses Elicited by an Intranasal DNA Priming/Intramuscular Recombinant Vaccinia Boosting Regimen
por: Qiu, Sugan, et al.
Publicado: (2014)

Intranasal Administration of Codium fragile Polysaccharide Elicits Anti-Cancer Immunity against Lewis Lung Carcinoma
por: Wang, Yuhua, et al.
Publicado: (2021)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
por: Li, Xingxing, et al.
Publicado: (2022)

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
por: Hua, Tao, et al.
Publicado: (2022)

Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy
por: Gulati, Neha, et al.
Publicado: (2013)

Effects of intranasal and intramuscular dexmedetomidine in cats receiving total intravenous propofol anesthesia
por: Hommuang, Kewvaree, et al.
Publicado: (2022)

Intranasal Vaccination with Chlamydia pneumoniae Induces Cross-Species Immunity against Genital Chlamydia muridarum Challenge in Mice
por: Manam, Srikanth, et al.
Publicado: (2013)

Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans
por: Striepens, Nadine, et al.
Publicado: (2013)

Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritis
por: Chuang, I-Chuan, et al.
Publicado: (2004)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
por: Deimel, Lachlan P., et al.
Publicado: (2022)

Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008)

Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies
por: Badamchi-Zadeh, Alexander, et al.
Publicado: (2015)

Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice
por: Sadeghi, Sahar, et al.
Publicado: (2021)

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial
por: Dietze, Paul, et al.
Publicado: (2019)

Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration
por: van IJzendoorn, Marinus H., et al.
Publicado: (2012)

Curdlan sulfate–O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination
por: Zhang, Shu, et al.
Publicado: (2018)

Intranasal Infection with Chlamydia abortus Induces Dose-Dependent Latency and Abortion in Sheep
por: Longbottom, David, et al.
Publicado: (2013)

Intramuscular Tranexamic Acid Administration on the Battlefield
por: Steele, David, et al.
Publicado: (2022)

Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model
por: Zheng, Mei, et al.
Publicado: (2016)

The Chlamydia psittaci Inclusion Membrane Protein 0556 Inhibits Human Neutrophils Apoptosis Through PI3K/AKT and NF-κB Signaling Pathways
por: He, Zhangping, et al.
Publicado: (2021)

Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization
por: Hernandez-Franco, Juan F., et al.
Publicado: (2023)

Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020)

Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier
por: Gao, Xiaoyi, et al.
Publicado: (2021)

The Use of Sodium Salicylate by Intravenous and Intramuscular Administration
por: Roy, Suresh Chandra
Publicado: (1926)

Chlamydia trachomatis GlgA Is Secreted into Host Cell Cytoplasm
por: Lu, Chunxue, et al.
Publicado: (2013)

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung
por: Morabito, Kaitlyn M., et al.
Publicado: (2016)

Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120
por: Jiang, Pengfei, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4lt2mktldvd7l0eu0g0gk6b4sq